Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
Tenorio AR, Jiang H, Zheng Y, Bastow B, Kuritzkes DR, Bartlett JA, Deeks SG, Landay AL, Riddler SA. Tenorio AR, et al. Among authors: landay al. AIDS Res Hum Retroviruses. 2009 Feb;25(2):135-9. doi: 10.1089/aid.2008.0200. AIDS Res Hum Retroviruses. 2009. PMID: 19239354 Free PMC article. Clinical Trial.
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.
Landay AL, Spritzler J, Kessler H, Mildvan D, Pu M, Fox L, O'Neil D, Schock B, Kuritzkes D, Lederman MM; AIDS Clinical Trials Group 5014 Team. Landay AL, et al. J Infect Dis. 2003 Nov 15;188(10):1444-54. doi: 10.1086/379041. Epub 2003 Nov 13. J Infect Dis. 2003. PMID: 14624369 Clinical Trial.
The effect of aging on T-regulatory cell frequency in HIV infection.
Tenorio AR, Spritzler J, Martinson J, Gichinga CN, Pollard RB, Lederman MM, Kalayjian RC, Landay AL. Tenorio AR, et al. Clin Immunol. 2009 Mar;130(3):298-303. doi: 10.1016/j.clim.2008.10.001. Epub 2008 Nov 12. Clin Immunol. 2009. PMID: 19008157 Free PMC article.
HIV: so near and yet so far.
Tenorio AR, Landay AL. Tenorio AR, et al. Curr HIV/AIDS Rep. 2013 Mar;10(1):1-2. doi: 10.1007/s11904-012-0151-7. Curr HIV/AIDS Rep. 2013. PMID: 23266604 No abstract available.
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.
Jilg N, Garcia-Broncano P, Peluso M, Segal FP, Bosch RJ, Roberts-Toler C, Chen SMY, Van Dam CN, Keefer MC, Kuritzkes DR, Landay AL, Deeks S, Yu XG, Sax PE, Li JZ; AIDS Clinical Trials Group A5308 Study Team. Jilg N, et al. J Infect Dis. 2020 Nov 9;222(11):1837-1842. doi: 10.1093/infdis/jiaa294. J Infect Dis. 2020. PMID: 32496516 Free PMC article.
CCR5 and CXCR4 expression after highly active antiretroviral therapy (HAART).
Smith KY, Kumar S, Pulvirenti JJ, Gianesin M, Kessler HA, Landay A. Smith KY, et al. Among authors: landay a. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):458-60. doi: 10.1097/00042560-200208010-00013. J Acquir Immune Defic Syndr. 2002. PMID: 12138354 No abstract available.
607 results